Papers call for transparency of clinical data

Two papers published on Tuesday in PLoS Medicine call for greater transparency of clinical trial data, but one authored by a group of European regulators warns of the risks associated with open access to trial data and calls for debate to establish data transparency standards.

A researcher from the Johns Hopkins University School of Medicine and colleagues wrote that full clinical trial reports for authorized drugs should be made publicly available to enable independent re-analysis of a drug's benefits and risks. ...